Connect with us

Hi, what are you looking for?

entertainment

Index – Abroad – Together with the Poles, Hungary can use the veto card in NATO

Index – Abroad – Together with the Poles, Hungary can use the veto card in NATO

Earlier, our paper also wrote about the fact that the name of Ursula von der Leyen, the President of the European Commission, was mentioned in the competition for the position of Secretary General of NATO. According to a diplomatic source, several NATO member states have recommended the politician to take over the leadership of the alliance in October this year.

NATO Secretary General Jens Stoltenberg will leave his post later this year after indicating he did not wish to extend his term until September 30.

There are no formal elections, and the 30-member Western Union chooses the new leader in private and by consensus. Americans don’t usually name a candidate, but the White House traditionally has a lot of say in who gets the job.

According to British sources, the United Kingdom will almost certainly veto von der Leyen’s appointment, citing his failure to achieve significant results as head of the German armed forces. the Corriere della Sera Other Member States will also decide in favor of the veto.

The Italian portal knows that, in addition to the United Kingdom, Hungary and Poland will vehemently oppose the appointment, as it has not forgiven Von der Leyen for the fights over the payment of EU money.

The President of the European Commission was denounced

Frédéric Baldan, a Belgian lobbyist accredited to EU institutions, recently reported on Ursula von der Leyen before the Belgian court, so at the end of the proceedings the immunity of the Belgian-born politician may be suspended because of the Pfizer scandal.

The background to the case is that Von der Leyen is suspected of having signed a €35 billion contract with Pfizer in May 2021 for the purchase of 1.8 billion doses of coronavirus vaccine. world economy books. It is rumored that the President of the European Court of Justice discussed the details with Albert Bourla, CEO of Pfizer.